| Typicality: | 0.337 |
| Saliency: | 0.280 |
| according to a nexira white paper | 9 | other |
| from its customers | 5 | transitive-object |
| on the fda | 2 | location |
| manufacturer → get → feedback | 7 |
| manufacturer → receive → feedback | 4 |
| manufacturer → seek → feedback | 3 |
| manufacturer → take → feedback | 3 |
| negative | neutral | positive |
| 0.158 | 0.477 | 0.365 |
| Raw frequency | 17 |
| Normalized frequency | 0.280 |
| Modifier score | 0.400 |
| Perplexity | 152.464 |